Clinical Trial: Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders

U.S., March 27 -- ClinicalTrials.gov registry received information related to the study (NCT06333652) titled 'Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders' on March 20.

Brief Summary: The researchers are testing a medication named ravulizumab for the treatment of severe preeclampsia and Hemolysis, Elevated Liver enzymes, Low Platelets (HELLP) syndrome.

Study Type: Interventional

Condition: Preeclampsia

Intervention: Drug: Ravulizumab

Intravenous infusion 100 mg/ml

Other Name: Ultomiris

Recruitment Status: Recruiting

Published by HT Digital Content Services with permission from Health Daily Digest....